High aldehyde dehydrogenase (ALDH) activity has been associated with stem and progenitor cells in various tissues. 
to be safe in clinical trials in patients with ischemic cardiovascular disease. e presence of ALDH br cells in the heart has not been evaluated so far. We have characterized ALDH br cells isolated from mouse hearts. 40 passages. ey expressed sarcomeric -actinin and could be differentiated along multiple mesenchymal lineages. However, the proportion of ALDH br cells declined with cell passage. In conclusion, the cardiac-derived ALDH br population is enriched for progenitor cells that exhibit mesenchymal progenitor-like characteristics and can be expanded in culture. e regenerative potential of cardiac-derived ALDH br cells remains to be evaluated.
Introduction
Growing evidence suggests the adult heart may harbor resident stem and progenitor cells that participate in adaptive responses to myocardial injury, and possibly in cellular homeostasis under normal conditions. In most studies, the prospective isolation of cardiac stem cells has relied upon the use of speci�c antibodies that recognize cell-surface antigens expressed by stem cells in other tissues, particularly by hematopoietic stem cells (HSCs). Cardiac stem cells expressing stem cell antigen-1 (Sca-1) or the stem cell factor receptor, c-kit (CD117), have been described [1, 2] . A distinct population of cardioblasts expressing the transcription factor islet-1 (Isl-1) and entering fully differentiated cardiomyocyte lineages has also been identi�ed [3, 4] . However, the expression of cell-surface epitopes can vary with the metabolic state of the cell and the experimental conditions used. erefore, no individual cell-surface antigen marker de�nitely identi�es a single entity of cardiac stem cell. Functional properties of tissue-resident stem cells that could be used for their prospective isolation, regardless of cellsurface marker expression, have been intensely searched for. It has been proposed that, irrespective of their lineal origin, stem cells may share common mechanisms to regulate selfrenewal and differentiation, and that candidate "stemness" genes may serve as universal stem cell markers.
Cai et al. [5] proposed that high aldehyde dehydrogenase (ALDH) activity is one of a small set of common characteristics shared by stem cells among tissues (recently reviewed by Balber [6] ). Few ALDH-bright (ALDH br ) pluripotential cells, measured by Alde�uor stain, gave rise to all somatic and reproductive cell lineages in tunicates [7, 8] . ALDH is a cytosolic enzyme responsible for the oxidation of intracellular aldehydes. It plays important roles in oxidation of alcohol and vitamin A, and in chemoresistance to cyclophosphamide. ALDH superfamily is highly conserved across species [9] . Nineteen ALDH isoforms are known in human. ALDH br , side scatter-low (SSC lo ) populations from murine and human bone marrow (BM) [10] [11] [12] [13] , umbilical cord blood (UCB) [14] [15] [16] [17] [18] [19] , cytokine-mobilized peripheral blood [20] , and circulating blood cells [21, 22] are enriched in stem and progenitor cells. e ALDH br SSC lo population includes virtually all human CD34
+ and CD133 + cells that establish long-term, multilineage hematopoietic colonies in culture or long-term, multilineage xenogras in immunode�cient mice [16] . More recently, ALDH br stem cells have been identi�ed in nonhematopoietic systems, such as circulating endothelial progenitor cells (EPCs) [21, 22] , neural stem cells [23, 24] , human muscle precursor cells with high myogenic activity [25, 26] , colonic stem cells [27] , and mammary stem cells [28] . Moreover, ALDH br cancer stem cells have been described in multiple types of cancer and shown to predict poor clinical outcomes in various contexts [27] [28] [29] .
We therefore asked whether the postnatal heart harbors ALDH br cells, as measured by Alde�uor stain. We found that the neonatal as well as the adult mouse heart harbors a relatively small population of ALDH br cells (≈1% of all nonmyocytic cells present in the heart), which is enriched for cells expressing Sca-1 and other progenitor cell markers. ALDH br cells, but not ALDH dim cells, adhered to plastic and grew in culture. e expanded population expressed sarcomericactinin, a cardiac marker, along with mesenchymal stem cell (MSC) markers. It could be induced to differentiate along multiple mesenchymal cell lineages. ese results suggest that ALDH may mark a population of cardiac-resident, MSClike progenitor cells that possess superior ex vivo growth characteristics.
Methods

Mice and Cell
Isolation. Neonatal (postnatal day 1), young adult (8 week-old), and aging (24 month-old) C57Bl/6 mice were purchased from Charles River Laboratories (France). Immediately aer the sacri�ce of the mice, the chest was opened, a canula was introduced into the le ventricular cavity, an incision was made in the right atrial wall, and the heart was perfused with heparinized PBS. e explanted heart was washed in PBS and cut into small pieces that were then placed in a Falcon tube (50 mL) ) were sorted using a Beckman Coulter MoFlo Astrios FACS system. Total mRNA from each cell subset was extracted using the RNeasy Micro kit (Qiagen). e different c-DNAs were generated using the Quantitect reverse transcription kit (Qiagen) from total mRNA obtained with a genomic DNA digestion step according to the manufacturer's instructions. cDNA (1 : 10 dilution) was used for quanti�cation using the RT 2 SYBR Green qPCR Kit (Qiagen) and the Rotor-Gene 2000 system (Qiagen) according to the manufacturer's instructions. Real-time PCR reactions (in triplicates) were set up in 10 L reaction volume with 5 L of RT 2 SYBR Green mix, 0.4 L of 10 M RT 2 qPCR Primer Assay, 3 L cDNA, and 1.6 L water. e polymerase was heat-activated for 10 min at 95 ∘ C, and the reactions were then cycled 50 times (95 ∘ C, 15 sec; 55 ∘ C, 40 sec; 72 ∘ C, 30 sec), followed by a melting step. Primers were obtained from (Qiagen). Relative expression was calculated with the comparative ΔCt method using GUSB as a reference gene.
Ex Vivo Cultures of
Cells. br sorted cells were also cultured in RPMI/FCS medium (RPMI 1640; Gibco, supplemented with 10% fetal calf serum). e AlamarBlue assay (Promega, Madison, WI, USA) was used to assess cell viability and growth. In a separate experiment, cells were cultured in the presence of imatinib (methanesulfonate salt, 0.1-10 M; LC Laboratories, Woburn, MA, USA), a inhibitor of receptor tyrosine kinases encoded by c-kit and platelet-derived growth factor receptor B (PDGFRB). Cells were incubated with imatinib for 42 h (in triplicates) before AlamarBlue was added. Absorbance was measured at 570 nm and 595 nm every hour during 6 hours, and AlamarBlue reduction was calculated.
Differentiation Potential of Expanded
Cells. Cells sorted on the basis of high ALDH activity were cultured for 8 months in MesenCult, which was then replaced by NH ChondroDiff Medium (for 21 days), NH OsteoDiff Medium (7 days), or AdipoDiff Medium (14 days; all from Miltenyi). Chondrogenic differentiation was assessed by immunostaining for type II collagen. To assess osteogenic and adipogenic differentiation, cells were incubated with 1% PFA for 10 min, followed by 2% Alizarin Red solution for 5 min and Oil Red-O solution for 15 min, respectively, and by 3 PBS-washes.
Results
3.1.
Cells in Neonatal and Young Adult Hearts. Freshly isolated nonmyocytic cells from enzymatically dissociated, neonatal or 8-week-old hearts were analyzed by �ow cytometry using the Alde�uor reagent. ALDH br cells amounted to 1.00 ± 0.59% of all nonmyocytic cells in the neonatal heart ( ) and to 0.99 ± 0.55% of these cells in the young adult heart ( , NS; Figure 1 ). Within the ALDH br population, the percentage of ALDH very-br cells in neonatal hearts was higher than in young adults (52. 1 ± 6.8 % versus 19. 9 ± 2. 2%; 0.05). Figure   6 (a)). However, >95%ALDH dim cells appeared to be viable, as assessed by DAPI, immediately aer the FACS procedure. Atrially derived bulk populations of nonmyocytic cells grew poorly. Puri�ed ALDH br cells gave rise to small numbers of cell colonies, each one apparently originating from a single cell, which formed a monolayer of plastic-adherent cells, which could be expanded for more than 40 passages (later passages were not tested). In one cell culture, the percentage of ALDH br cells at passage 7 was 11%; however, this parameter was not systematically measured at various time points. Growth rates in MesenCult medium were higher than in RPMI/FCS medium ( Figure 6(b) ). is was con�rmed using the AlamarBlue assay ( Figure 6(c) ). Imatinib inhibited cell growth in a dose-dependent manner (Figure 6(d) ).
Cells in Atria and
Immunophenotype of Culture-Expanded
Cells. e marker pro�le of expanded ALDH br cells (P11-13) was analyzed by �ow cytometry (Figure 7 ). Cells expanded in MesenCult medium stained positive for Sca-1, CD29, CD44, CD105, CD106, and, in part, CD146 and CD14. ey stained negative for CD45, CD11b, CD31, and CD133. To assess whether the culture medium affected marker expression, cells were also grown in RPMI/FCS. e immunophenotype of these cells was similar to those grown in MesenCult, although larger cell subsets stained positive for c-kit, CD140b (PDGFRB) and NG2 chondroitin sulfate proteoglycan (Figures 7 (b) and 7(c)). NG2 essentially colocalized with CD140b and CD146 (Figure 7(d) ). c-kit expression was demonstrated by immunocytochemistry (Figure 7(e) ). 
Expanded Cells Express
Discussion
Growing evidence suggests high ALDH activity may be a common feature shared by stem and progenitor cells across normal tissues, as well as in cancer. Human UCB and BM cells possessing high ALDH activity have shown angiogenic activity in preclinical studies [30] [31] [32] and have been used safely in phase I clinical trials in patients with ischemic cardiovascular disease [33] [34] [35] .
We characterized, for the �rst time, ALDH br cells isolated from the heart. Approximately one percent of all nonmyocytic cells present in the young adult mouse heart were ALDH br , as measured by Alde�uor stain (Figure 1 ). e neonatal heart contained a similar number of ALDH br cells, although with a higher proportion of cells exhibiting very high ALDH activity (ALDH very-br ) compared to the young adult heart. e frequency of ALDH br cells in the population isolated from the atria was approximately 10-fold higher than in cells derived from ventricles (Figure 2) . is observation has analogies with previous reports on increased numbers of putative stem/progenitor cells, such as DNA-label retaining cells in rodents [36, 37] and c-kit + cells in human [38] , in atria relative to ventricles. In the present study, ALDH phenotype. Nevertheless, the slightly different SSC properties of atrial and ventricular cells may suggest differences in the cellular composition of the ALDH br population depending on the cardiac chamber of origin. is issue remains to be addressed in future studies.
Freshly isolated ALDH br cells exhibited a heterogeneous phenotype, re�ecting a mixture of different cell types ( Figures  3 and 4) . is population was signi�cantly enriched for cells expressing Sca-1, the early hematopoietic and EPC marker CD34, the MSC marker CD90, the hyaluronic acid receptor CD44, and vascular cell adhesion molecule-1 (CD106). CD44 and CD106 were the most highly enriched markers in the ALDH br versus ALDH dim population (34.3 and 24.1 fold-increases, resp.). Previous studies associated CD44 and CD106 expression with MSCs [39] . However, a recent study showed that freshly isolated murine and human BM stromal cells did not express CD44 and CD106, but they could acquire expression of these antigens in vitro [40] . CD44 + CD24
− cells have been proposed to represent cancer stem cells in breast cancer [41] , as well as in head and neck squamous cell carcinoma (the latter includes an ALDH1 + CD44 + CD24 − stem cell subset) [42] . In the present study, ALDH very-br cells were highly enriched for Sca-1 and CD90, but only moderately so for CD34, possibly re�ecting a predominant MSC-like subpopulation with fewer hematopoietic/vascular progenitors compared to ALDH br cells with lower levels of ALDH activity. e ALDH br population was signi�-cantly depleted for common leukocyte antigen (CD45), the endothelial marker CD31, and CD38 (an antigen expressed by the differentiating progeny of CD34 + CD38 -hematopoietic/vascular progenitors). ALDH very-br cells were further depleted for lineage differentiation markers compared to ALDH br cells. us, the ALDH br population was enriched for MSC-like progenitors and depleted for differentiating hematopoietic and endothelial cells. ALDH br cells formed a few plastic-adherent colonies in each culture well. Each colony apparently originated from a single cell, providing observational evidence of clonal expansion, even though this was not �rmly established using a clonogenic assay. e mechanism responsible for the selective growth of ALDH br cells in culture remains unclear. To initially address this question, we determined the respective contributions of selected ALDH isozymes to ALDH activity, measured by Alde�uor stain. Fi�een ALDH isozymes have been described in mice [43] and 19 in human [9, 44] . ey play different biological roles that vary among cell types and species. ALDH1A1, the ALDH isozyme most highly overexpressed in human BM ALDH br versus ALDH dim cells [44] , was believed to be responsible for ALDH activity, measured by Alde�uor stain, in BM and other tissues. However, recent �ndings in genetically modi�ed mice demonstrated that ALDH1A1 was dispensable for stem cell function in the mouse hematopoietic and nervous systems [45] . ALDH1 was identi�ed as a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome in breast cancer [28] . In a distinct study, shRNA knock-down data indicated that ALDH1A3, not ALDH1A1, correlated best with ALDH activity in breast cancer stem cells [46] . ALDH1A1 and ALDH3A1 were highly expressed in nonsmall cell lung cancer, and knock-down of these ALDH isoforms were associated with in vitro functional changes in the proliferation and motility of these cells [47] . Human ALDH1A1, ALDH1A2, ALDH1A3, and ALDH8A1 function in retinoic acid cell signaling via retinoic acid production by oxidation of all-trans-retinal and 9-cis-retinal [6, 46] . ALDH2, a mitochondrial isozyme that mediates both the detoxi�cation of reactive aldehydes and the bioactivation of nitroglycerin to nitric oxide, mediates cytoprotection in the heart [48] . Recent data indicated that the aldehydeoxidizing activity of mouse HSCs, measured by Alde�uor stain, was due to the ALDH2 isozyme and correlated with protection against acetaldehyde toxicity [49] . Mice de�cient in both Fanconi anemia pathway-mediated DNA repair and acetaldehyde detoxi�cation showed more than a 6��-fold reduction in the HSC pool.
Based on these reports, we measured the expression of ALDH1A1, ALDH1A2, ALDH1A3, and ALDH2 gene transcripts in puri�ed ALDH dim , ALDH br , and ALDH was detectable in ALDH br and ALDH very-br cells, albeit at lower levels compared to ALDH1A1 and ALDH1A2, but not in ALDH dim cells. us, ALDH1A1 correlated best with ALDH activity; however, contributory roles of ALDH1A2, ALDH1A3, and ALDH2 to ALDH activity are possible based on our data. While the present analysis included the four ALDH isoforms most oen associated with ALDH activity in previous reports [44] [45] [46] [47] [48] [49] , it should be completed to include the remaining ALDH isoforms. In addition, shRNA knockdown experiments are needed for identifying the ALDH isozyme(s) responsible for ALDH activity in these cells.
Recent data suggested BM and UCB ALDH br cells might repair ischemic tissues in vivo by releasing angiogenic factors [30] [31] [32] 7.0, resp.) [44] . We therefore measured mRNA expression of these angiogenic genes in cardiac-derived cells but found no correlation with ALDH activity (besides the preliminary observation that angiopoietin-1 transcripts were detectable in ALDH br and ALDH very-br cells but not in ALDH dim cells). e angiogenic potential of cardiac-derived ALDH br cells remains to be addressed in future studies. Previous reports showed that ALDH br MSCs from human UCB were more responsive to hypoxia than their ALDH dim counterparts, with upregulation of Flt-1, CXCR4, and angiopoietin-2 [50] . e same group reported that ALDH dim EPCs, but not ALDH br EPCs, from human UCB upregulated hypoxia-inducible factor proteins as well as VEGF, CXCR4, and GLUT-1 mRNAs under hypoxic conditions [22] . e introduction of ALDH dim EPCs signi�cantly reduced ischemic tissue damage in a mouse �ap model, whereas ALDH br EPCs were ineffective.
BioMed Research International 13 ese �ndings suggested varying angiogenic activities of ALDH br cells depending on the cell type studied. In the present study, plastic-adherent cell clusters grew rapidly and could be passaged more than 40 times (later passages were not tested). Growth rates in complete MesenCult medium were higher than in RPMI/FCS ( Figure  6 ). Imatinib, which selectively inhibits PDGFRB (CD140b) and c-kit tyrosine kinases with a similar potency [51] , reduced cell proliferation in a dose-dependent manner. Expression of PDGFRB and c-kit was detected in subsets of expanded cells. e effect of Imatinib might re�ect a role for PDGFRB and/or c-kit in the proliferation of these cells. Previous studies showed that ALDH br MSCs from UCB proliferated more than their ALDH dim counterparts [50] , whereas ALDH dim EPCs proliferated more than ALDH br EPCs [22] . Proliferative properties correlated with angiogenic activities in these populations. Again, the association of ALDH and proliferation may vary among cell types. e immunophenotype of expanded ALDH br cardiac cells resembled that of freshly isolated ALDH br cells ( Figure 7 ). Positive stains for pericytic markers (NG2, CD146, and CD140b) were consistent with a MSC-like phenotype. It has been shown that perivascular cells of arterioles and capillaries from many tissues express pericytic markers and show MSClike and angiogenic features [52] [53] [54] . In the present study, expanded cells stained positive for sarcomeric -actinin, a cardiac marker, and exhibited differentiation potential along multiple mesenchymal lineages. Previous data showed that aldehyde dehydrogenase activity did not increase the chondrogenic potential of human adipose-derived adult stem cells [55] . Recent reports showed that human BM contained ALDH br multipotential mesenchymal progenitor cells (MPCs), besides ALDH br HSCs and EPCs [12, 56] . ese MPCs strongly expressed ALDH, expressed embryonic markers not present in mesenchymal cells, and could be differentiated to microvascular endothelial cells and mesenchymal cells. e latter lacked strong ALDH expression and could not be induced to back differentiate into MPCs.
We observed a loss of ALDH br cells with cell passage (e.g., only 11% of cells at passage 7 were still ALDH br ).
Whether this loss of ALDH br cells with time re�ected cellular adaptation to ex vivo conditions or the replacement of early progenitors by a progeny of late progenitor and precursor cells remains unclear. e observation that growth rates and the immunophenotype remained stable for more than 30 and 10 passages, respectively, seemed not to support cell differentiation. ALDH as a stem/progenitor cell marker has chie�y been used in freshly isolated cells and tissues, as opposed to expanded cell populations. e signi�cance of ALDH in culture-expanded cells is unclear, as is its contribution to stem cell fate. e aforementioned observation that the mesenchymal cell progeny of ALDH br human BM cells lacked strong ALDH expression and could not be induced to back differentiate into MPCs suggested a parallel loss of ALDH expression and cell potency [56] .
In conclusion, cardiac-derived ALDH br cells are progenitor cells with MSC-like phenotype and function and with superior ex vivo growth characteristics compared to their ALDH dim counterparts. Further studies are needed for assessing the regenerative potential of these cells in animal models of heart disease.
